SRx Health Solutions Inc. (SRXH)
AMEX·Healthcare·Drug Manufacturers - General
$0.12
-0.59%
Mkt Cap $4.28M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 13, 2026 | — | $2.81M | — | — | -$0.17 | — | — | — |
| Q4 2025 Nov 10, 2025 | — | -$24.77M | — | — | -$0.40 | — | — | — |
| Q3 2025 Sep 30, 2025 | — | $8.37M | — | — | -$0.74 | — | — | — |
| Q2 2025 May 15, 2025 | — | $5.00M | — | — | -$0.37 | — | — | — |
| Q1 2025 Mar 27, 2025 | $12.90M | $4.97M | -61.44% | -$4.84 | -$0.50 | +89.67% | — | — |
| Q4 2024 Nov 12, 2024 | $15.50M | $8.42M | -45.69% | -$2.20 | -$0.54 | +75.45% | — | — |
| Q2 2024 Jun 30, 2024 | $22.00M | $31.21M | +41.86% | -$2.20 | -$0.10 | +95.28% | — | — |
| Q2 2024 Apr 12, 2024 | — | $4.29M | — | — | -$15.18 | — | — | — |
| Q1 2024 Mar 30, 2024 | $22.40M | $4.30M | -80.82% | — | -$1.96 | — | — | — |
| Q4 2023 Nov 13, 2023 | $13.80M | $13.12M | -4.95% | -$2.64 | -$2.20 | +16.67% | — | — |
| Q3 2023 Aug 21, 2023 | $19.50M | $10.54M | -45.97% | -$2.20 | -$4.40 | -100.00% | — | — |